4-butyrolactone has been researched along with Cognition Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, M; Xie, X; Xin, J; Yang, Y; Zhang, J | 1 |
Feng, ZB; Li, JJ; Lu, YP; Qian, ZM; Zhao, P; Zhu, L; Zhu, Q | 1 |
Du, JR; Kuang, X; Liu, YX; Peng, HY; Zhang, GY | 1 |
3 other study(ies) available for 4-butyrolactone and Cognition Disorders
Article | Year |
---|---|
Radix Angelica Sinensis that contains the component Z-ligustilide promotes adult neurogenesis to mediate recovery from cognitive impairment.
Topics: 4-Butyrolactone; Adult Stem Cells; Angelica sinensis; Animals; Blotting, Western; Cell Differentiation; Cognition Disorders; Cranial Irradiation; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Immunohistochemistry; Male; Neural Stem Cells; Neurodegenerative Diseases; Neurogenesis; Rats; Rats, Wistar | 2013 |
Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Cognition Disorders; Galactose; GAP-43 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Neurotoxicity Syndromes; Sodium-Potassium-Exchanging ATPase; Statistics, Nonparametric | 2015 |
Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats.
Topics: 4-Butyrolactone; Acetylcholinesterase; Angelica sinensis; Animals; Antioxidants; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Choline O-Acetyltransferase; Cognition Disorders; Male; Maze Learning; Parasympathetic Nervous System; Prosencephalon; Rats; Rats, Wistar; Reversal Learning | 2008 |